Feedback / Questions
sifalimumab (MDX-1103) - AstraZeneca
AstraZeneca: Q2 2014 Results
(AstraZeneca)
-
Aug 1, 2014 -
Anticipated data from P2b trial for SLE at ACR (Nov 14-19, 2014)
Anticipated P2b data
•
Immunology • Lupus
http://www.astrazeneca.com/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-Disposition&blobheadername2=MDT-Type&blobheadervalue1=inline%3B+filename%3DDownload-clinical-trial-programmes-summary.pdf&blobheadervalue2=abinary%3B+charset%3DUTF-8&blobkey=id&blobtable=MungoBlobs&blobwhere=1285676555739&ssbinary=true
Aug 1, 2014
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.